Bilcare Share Price | Bilcare Stock Screener
BI
Healthcare Technology
Share Price NSE
₹62.47
▲
0.47 (0.76%)
Share Price BSE
₹62.20
▲
0.08 (0.13%)
As of May 27, 2026, the Bilcare share price (NSE: BI) is ₹62.47 on NSE and ₹62.20 on BSE, up 0.76% from the previous close, with shares trading between ₹62.47 and ₹63.31, and a 52-week range of ₹59.75–₹72.10.
Check BI 52-week performance for the annual price range and momentum.
Use the Bilcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Bilcare Market Cap
₹153.04 Cr.
BI P/E Ratio (TTM)
-3.69
Bilcare P/B Ratio
0.33
EPS (TTM)
₹-12.23
Dividend Yield
-
Debt to Equity
1.98
BI 52 Week High
₹72.10
Bilcare 52 Week Low
₹59.75
Operating Margin
6.00%
Profit Margin
-6.95%
BI Revenue (TTM)
₹187.00
EBITDA
₹16.00
Net Income
₹-13.00
Total Assets
₹1,417.00
Total Equity
₹590.00
Bilcare Share Price Chart
Screen Bilcare share price with an interactive chart. Analyse BI price trends and volatility across different timeframes.
Bilcare Company Profile - Fundamental Screener
Screen Bilcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for BI shares.
Sector
Healthcare
Industry
Healthcare Technology
Sub-Sector
Healthcare Technology
Segment
E
ISIN
INE986A01012
Bilcare Balance Sheet Screener
Screen BI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,417 | 1,568 | 1,593 | 1,127 | 1,064 | 1,112 | 3,159 | 3,479 | 3,507 | 3,682 |
| Current Assets | 343 | 411 | 343 | 421 | 337 | 365 | 882 | 933 | 788 | 907 |
| Fixed Assets | 949 | 1,038 | 1,046 | 465 | 494 | 534 | 2,006 | 2,180 | 2,403 | 2,433 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 488 | 572 | 551 | 563 | 586 | 624 | 1,096 | 1,037 | 2,085 | 2,152 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 590 | 646 | 704 | 161 | 164 | 176 | -6 | 463 | 676 | 772 |
| Share Capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
| Reserves & Surplus | 446 | 474 | 507 | 52 | 63 | 85 | -93 | 376 | 590 | 689 |
Bilcare Income Statement Screener - Profit & Revenue Analysis
Screen Bilcare income statement and profit fundamentals.
Analyze BI quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Bilcare share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 187 | 183 | 192 | 215 | 202 | 206 | 198 | 198 | 209 | 179 | 200 | 186 | 465 | 246 | 264 |
| Expenses | 170 | 175 | 175 | 187 | 197 | 204 | 175 | 175 | 208 | 158 | 183 | 170 | 219 | 241 | 240 |
| EBITDA | 16 | 8 | 17 | 29 | 4 | 2 | 23 | 23 | 1 | 21 | 17 | 16 | 246 | 6 | 24 |
| Operating Profit % | 6.00% | 2.00% | 6.00% | 4.00% | 0.00% | -1.00% | 10.00% | 10.00% | -4.00% | 10.00% | 4.00% | 7.00% | 6.00% | 2.00% | 6.00% |
| Depreciation | 12 | 12 | 12 | 12 | 12 | 11 | 12 | 12 | 13 | 11 | 11 | 11 | 9 | 10 | 9 |
| Interest | 17 | 19 | 19 | 19 | 20 | 24 | 21 | 21 | 23 | 21 | 20 | 19 | 11 | 16 | 16 |
| Profit Before Tax | -13 | -24 | -13 | -2 | -27 | -33 | -10 | -10 | -35 | -10 | -13 | -13 | 225 | -20 | -2 |
| Tax | 0 | 0 | -3 | -7 | -11 | -3 | 5 | 5 | -16 | 3 | -1 | 0 | 147 | -1 | 1 |
| Net Profit | -13 | -23 | -10 | 5 | -16 | -30 | -15 | -15 | -20 | -14 | -12 | -13 | 78 | -19 | -3 |
| EPS | -2.53 | -5.25 | -1.61 | 4.48 | -3.05 | -6.81 | -2.71 | -2.71 | -4.63 | -2.91 | -3.22 | -3.36 | 19.63 | -7.98 | -2.42 |
Bilcare Cash Flow Screener - Liquidity Fundamentals
Screen BI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 63 | -7 | 41 | 72 | 256 | 206 | 99 | 300 | 177 | -315 |
| Investing Activities | -106 | 36 | -4 | 2 | 1,309 | -104 | -203 | -129 | -358 | 247 |
| Financing Activities | 36 | -19 | -55 | -83 | -1,600 | -103 | 91 | -155 | 149 | 119 |
| Net Cash Flow | -8 | 10 | -18 | -9 | -35 | -1 | -13 | 16 | -32 | 50 |
Bilcare Shareholding Pattern Screener
See Bilcare shareholding pattern with promoter, FII, and DII holdings.
Check Bilcare promoter holding and ownership changes for BI on TickJournal.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% | 30.01% |
| FII Holding | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 45.18% | 45.45% | 45.40% | 44.96% | 44.68% | 45.40% | 45.51% | 45.57% |
| Other Holding | 24.76% | 24.49% | 24.54% | 24.99% | 25.26% | 24.55% | 24.43% | 24.37% |
| Shareholder Count | 15,824 | 16,068 | 16,513 | 17,047 | 17,586 | 18,496 | 18,241 | 18,783 |
Bilcare Share Dividend Screener - Share Yield Analysis
Check Bilcare dividend history with payout and yield data.
View Bilcare dividend details including ex-dates and amounts for BI stock.
Bilcare Stock Index Membership
See which indices include Bilcare stock.
Check BI index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Bilcare Market Events Screener - Corporate Actions
Get Bilcare corporate actions including splits, bonuses, and buybacks.
Check Bilcare stock events that may affect BI share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 31.15% | ||
| Annual General Meeting | NA | -7.47% | ||
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 1.62% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 2.30% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -5.12% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -1.45% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -0.20% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -13.94% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -5.03% |
Bilcare Competitors Screener - Peer Comparison
Screen BI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 18,769 | 58.75 | 3,739 | 0.66% | 324 | 53.36 |
| Indegene | 12,570 | 30.51 | 3,511 | 19.14% | 349 | 50.49 |
| Suven Life Sciences | 7,167 | -25.38 | 7 | -59.60% | -276 | 75.18 |
| Vimta Labs | 2,053 | 35.09 | 322 | 0.22% | 41 | 45.20 |
| Take Solutions | 442 | 40.03 | 54 | 431.27% | 11 | 34.57 |
| Jeevan Scientific Technology | 162 | -78.68 | 48 | 17.87% | 0 | 52.16 |
| Bilcare | 153 | -3.69 | 807 | 4.78% | -56 | 68.63 |
| Adeshwar Meditex | 25 | 33.09 | 56 | -33.21% | 1 | 23.20 |
| Vanta Bioscience | 16 | -1.21 | 2 | -78.57% | -13 | 62.64 |
Bilcare Company Announcements - News Screener
Screen BI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-27 | Board Meeting Intimation for To Consider And Approve The Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended On 31 March 2026. | - |
| 2026-04-29 | Non-Applicability Of SEBI Circular No. SEBI/HO/DDHS/DDHS-RACPOD1/P/ CIR/2023/172 Dated October 19 2023 | - |
| 2026-04-25 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-04-16 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-30 | Update On Voluntary Liquidation Of Wholly Owned Subsidiary - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 | - |
| 2026-03-30 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-03-30 | Announcement Under Regulation 30 | - |
| 2026-03-25 | Closure of Trading Window | - |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-12 | Exercise Of Right Of Conversion Of Convertible Warrants | - |
| 2026-02-12 | Redemption Of Preference Shares | - |
| 2026-02-12 | Unaudited Financials Result (Standalone And Consolidated) For The Quarter And Nine Months Ended 31.12.2025 Along With Limited Review Report. | - |
| 2026-02-12 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 12 February 2026. | - |
| 2026-02-06 | Board Meeting Intimation for For Considering And Approving The Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2025. | - |
| 2026-01-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-01-07 | Intimation For Change In Email Address Of The RTA | - |
| 2025-12-26 | Closure of Trading Window | - |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-11-14 | Unaudited Financials Result (Standalone And Consolidated) For The Quarter And Half Year Ended 30.09.2025 Along With Limited Review Report. | - |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On 14Th November 2025 | - |